2009-2014年美国医院脓毒症发病率及趋势:基于临床数据与索赔数据的对比
该回顾性队列研究纳入2009-2014年409家学术、社区及联邦医院收治的成人患者,采用适配Sepsis-3标准的临床指标(疑似感染+急性器官功能障碍)识别脓毒症,并与基于国际疾病分类第九版临床修订版严重脓毒症或脓毒性休克编码的索赔数据比较。2014年临床标准识别173 690例脓毒症,占2 901 019例成人住院的6.0%,住院死亡率15.0%,6.2%出院转临终关怀。2009-2014年临床标准发病率稳定(相对变化+0.6%/年,95%CI -2.3%至3.5%,P=.67),而索赔标准发病率上升(+10.3%/年,95%CI 7.2%至13.3%,P<.001);临床标准住院死亡率下降(-3.3%/年,95%CI -5.6%至-1.0%,P=.004),但死亡或转临终关怀复合终点无显著变化(-1.3%/年,95%CI -3.2%至0.6%,P=.19)。临床标准识别脓毒症的敏感性高于索赔标准(69.7% vs 32.3%,P<.001),阳性预测值相当(70.4% vs 75.2%,P=.23)。
要点
- 2014年临床标准脓毒症占成人住院6.0%(173 690/2 901 019),住院死亡率15.0%,6.2%出院转临终关怀。
- 2009-2014年临床标准脓毒症发病率稳定(+0.6%/年,95%CI -2.3%至3.5%,P=.67),索赔标准发病率上升(+10.3%/年,95%CI 7.2%至13.3%,P<.001)。
- 临床标准住院死亡率下降(-3.3%/年,95%CI -5.6%至-1.0%,P=.004),但死亡或转临终关怀复合终点无显著变化(-1.3%/年,95%CI -3.2%至0.6%,P=.19)。
- 临床标准识别脓毒症敏感性69.7%(95%CI 52.9%至92.0%)高于索赔标准32.3%(95%CI 24.4%至43.0%),P<.001;阳性预测值两者相当(70.4% vs 75.2%,P=.23)。
- 基于电子健康记录的临床数据较索赔数据提供更客观的脓毒症监测估计。
适用人群与场景
- 2009-2014年收治于409家学术、社区及联邦医院的成人患者。
诊断标准与关键阈值
- 脓毒症识别采用适配Sepsis-3标准的临床指标:疑似感染同时存在急性器官功能障碍,用于客观且一致的电子健康记录监测。
- 索赔数据采用国际疾病分类第九版临床修订版严重脓毒症或脓毒性休克编码识别。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入409家医院2009-2014年成人患者;2014年临床标准识别173 690例脓毒症(平均年龄66.5岁,SD 15.5;女性77 660例,42.4%),占2 901 019例成人住院的6.0%。
- 临床标准脓毒症患者中26 061例(15.0%)住院死亡,10 731例(6.2%)出院转临终关怀。
- 2009-2014年临床标准脓毒症发病率稳定(相对变化+0.6%/年,95%CI -2.3%至3.5%,P=.67),索赔标准发病率上升(+10.3%/年,95%CI 7.2%至13.3%,P<.001)。
- 临床标准住院死亡率下降(-3.3%/年,95%CI -5.6%至-1.0%,P=.004),死亡或转临终关怀复合终点无显著变化(-1.3%/年,95%CI -3.2%至0.6%,P=.19);索赔标准住院死亡率下降(-7.0%/年,95%CI -8.8%至-5.2%,P<.001),死亡或转临终关怀复合终点下降(-4.5%/年,95%CI -6.1%至-2.8%,P<.001)。
- 临床标准识别脓毒症敏感性69.7%(95%CI 52.9%至92.0%)高于索赔标准32.3%(95%CI 24.4%至43.0%),P<.001;阳性预测值临床标准70.4%(95%CI 64.0%至76.8%)与索赔标准75.2%(95%CI 69.8%至80.6%)相当,P=.23。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 基于电子健康记录的临床数据较索赔数据提供更客观的脓毒症监测估计,索赔数据可能因诊断和编码实践变化而缺乏临床真实性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Estimates from claims-based analyses suggest that the incidence of sepsis is increasing and mortality rates from sepsis are decreasing. However, estimates from claims data may lack clinical fidelity and can be affected by changing diagnosis and coding practices over time.
OBJECTIVE: To estimate the US national incidence of sepsis and trends using detailed clinical data from the electronic health record (EHR) systems of diverse hospitals.
DESIGN, SETTING, AND POPULATION: Retrospective cohort study of adult patients admitted to 409 academic, community, and federal hospitals from 2009-2014.
EXPOSURES: Sepsis was identified using clinical indicators of presumed infection and concurrent acute organ dysfunction, adapting Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria for objective and consistent EHR-based surveillance.
MAIN OUTCOMES AND MEASURES: Sepsis incidence, outcomes, and trends from 2009-2014 were calculated using regression models and compared with claims-based estimates using International Classification of Diseases, Ninth Revision, Clinical Modification codes for severe sepsis or septic shock. Case-finding criteria were validated against Sepsis-3 criteria using medical record reviews.
RESULTS: A total of 173 690 sepsis cases (mean age, 66.5 [SD, 15.5] y; 77 660 [42.4%] women) were identified using clinical criteria among 2 901 019 adults admitted to study hospitals in 2014 (6.0% incidence). Of these, 26 061 (15.0%) died in the hospital and 10 731 (6.2%) were discharged to hospice. From 2009-2014, sepsis incidence using clinical criteria was stable (+0.6% relative change/y [95% CI, -2.3% to 3.5%], P = .67) whereas incidence per claims increased (+10.3%/y [95% CI, 7.2% to 13.3%], P < .001). In-hospital mortality using clinical criteria declined (-3.3%/y [95% CI, -5.6% to -1.0%], P = .004), but there was no significant change in the combined outcome of death or discharge to hospice (-1.3%/y [95% CI, -3.2% to 0.6%], P = .19). In contrast, mortality using claims declined significantly (-7.0%/y [95% CI, -8.8% to -5.2%], P < .001), as did death or discharge to hospice (-4.5%/y [95% CI, -6.1% to -2.8%], P < .001). Clinical criteria were more sensitive in identifying sepsis than claims (69.7% [95% CI, 52.9% to 92.0%] vs 32.3% [95% CI, 24.4% to 43.0%], P < .001), with comparable positive predictive value (70.4% [95% CI, 64.0% to 76.8%] vs 75.2% [95% CI, 69.8% to 80.6%], P = .23).
CONCLUSIONS AND RELEVANCE: In clinical data from 409 hospitals, sepsis was present in 6% of adult hospitalizations, and in contrast to claims-based analyses, neither the incidence of sepsis nor the combined outcome of death or discharge to hospice changed significantly between 2009-2014. The findings also suggest that EHR-based clinical data provide more objective estimates than claims-based data for sepsis surveillance.
参考来源
- Rhee C, Dantes R, Epstein L, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017. PMID: 28903154. doi:10.1001/jama.2017.13836
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。